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In recent years, many medically promising antibiotics have been discovered in nature,            
especially in insect-microbe symbioses. One of the better-studied examples of this kind of             
defensive relationship is that of fungus-growing ants and the antibiotic-producing          
Actinobacteria. These bacteria produce several defensive chemicals with myriad uses, including           
one antibiotic that inhibits the growth of several bacterial strains, including other Actinobacteria.             
This antibiotic (known as nocamycin O) is a promising candidate for medicinal use due to its                
similarities to bacterial RNA polymerase inhibitors tirandamycin and streptolydigin, which          
inhibit several human pathogens. The determination of the structure of nocamycin O will be an               
important first step toward determining its function and its potential utility in the medical field.               
This can be done efficiently and accurately using nuclear magnetic resonance spectroscopy            
(NMR). NMR can be used on its own to attempt to solve the structure of a compound, or in                   
tandem with virtual chemical shift calculations that act as a check to correct the              
experimentally-derived structure. Overall, NMR and chemical shift calculations have become          
integral components to biochemical and biomedical research because they make structure           
elucidation much easier. My research sought to confirm the structure of nocamycin O using prior               
NMR data for the compound, as well as novel 2D NMR data collected in MeOD and DMSO                 
with complementary ​13​C-NMR spectrum calculations performed using DFT in Spartan ‘18.           
Comparative analysis of NMR spectra for nocamycin O and nocamycin I revealed key             
differences in chemical shift values; the carbon with the additional -OH in nocamycin O              
experienced a shift change of almost 40 ppm, while other carbons in the molecule showed a                
change of 5-10 ppm. These changes were likely due to a difference in nuclear environment at                




Novel Antibiotic Discovery: Methods 
Over the last few decades, more and more highly antibiotic-resistant pathogenic bacteria            
have been discovered. This necessitates the introduction and use in medicine of new antibiotics              
that bacteria have not yet evolved to resist. However, the rate of approval of new antibiotics has                 
not kept pace with need and has decreased dramatically in the last twenty years.​1 The most                
common traditional methods of antibiotic discovery are discovery-based chemical screening          
(screening small molecules for a certain desired activity without prior knowledge of their             
functions), and target-oriented screening (focused on identifying compounds that attack a known            
target), but these methods have grown ineffective.​2 The slowdown may be due to the rediscovery               
of many already-known substances, as it appears that certain classes of molecules are more likely               
to be discovered in these types of screening campaigns. To combat that, combinatorial chemistry              
was created, which involves ​in silico ​screening of fragments and experimental screening of             
fragment libraries followed by linkage of promising fragments in hope of creating a functional              
and useful drug.​3 However, though many new chemical compounds have been discovered, few             
have proven at all useful in terms of antibiotic or antifungal activity. This is because the                
combinatorial chemistry methods appear to only cover a limited amount of the chemical             
diversity represented in most chemical libraries.​2 Most drugs currently in use, as well as those               
produced in nature, show a much more diverse representation of chemical types that have more               
diverse and potent functions. The discovery of more of these diverse and well-functioning             
compounds could be achieved through natural products discovery, but not in the traditional             
sense. Instead of focusing on high-throughput screening or chimerically stitching two functional            
parts together, the attention should be on finding more naturally-occurring compounds, in            
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particular from plants and microbes and especially from defensive symbioses. In recent years,             
this type of natural products research has been the most productive in terms of new drug                
discoveries to be tested. There are currently over 100 new naturally-derived drugs in clinical              
development, mainly as cancer treatments and antibiotics.​1   
 
Nocamycin O as a Potential Antibiotic for Commercial Use 
In terms of novel antibiotic discovery, insect-microbe symbioses have shown much           
promise in recent years. These types of symbioses are common in many different types of               
animals and can come in two forms. Nutritional symbioses imply that the bacteria either              
produces nutrients the host needs or aids with digestion, while defensive symbiosis usually             
means that the bacteria produces a chemical that the host weaponizes for its own defense.​4-7 One                
of the more promising and better-studied examples of this kind of defensive relationship is that               
of fungus-growing ants and the antibiotic-producing Actinobacteria. The bacteria live off of            
secretions produced by the ant, and in return, they manufacture a wide variety of molecules with                
demonstrated antibacterial properties.​7,8 The presence of ​Actinobacteria ​has been shown to           
correlate with the efficacy of the ants’ efforts to suppress attacks by the pathogen ​Escovopsis​,               
which feeds upon the cultivar fungus that is the ants’ main food source (Figure 1). Antifungal                
molecules were also isolated from strains of ​Streptomyces found in similar fungus gardens on the               
same types of ants; their general function is suppression of nest pathogens, and they represent an                




Figure 1: ​Graphic representation of the symbiotic relationship between fungus-growing  
ants and some strains of Actinobacteria, adapted from Kim et. al. (2019). 
A particularly interesting facet of this symbiosis is that most strains of Actinobacteria             
show strong antagonistic effects against other Actinobacteria ​strains isolated from different ants.            
This is likely because when they coexist in the same environment, Actinobacteria ​are in direct               
competition with each other to maintain their favorable position in the symbiosis. This is              
well-illustrated in the response of ​Trachymyrmex septentrionalis​-associated Actinobacteria ​to         
other types of Actinobacteria.​9 Most of the bacterial isolates coming from ​T. septentrionalis             
show weak or no inhibition of other types of Actinobacteria also associated with other ​T.               
septentrionalis ​ants and extremely strong inhibition of the other Actinobacteria 17SM-1 and            
18AZ-4, which come from ​T. smithi ​and T. arizonensis ants respectively.​9 All of the strains that                
showed any inhibition at all were able to efficiently inhibit the growth of other types of                
Actinobacteria ​and many Gram-positive bacteria including the human pathogens ​Staphylococcus          
aureus and ​Enterococcus faecalis​.​9 The fact that the paradigm of this particular defensive             
symbiosis parallels human medicine (both use antagonistic molecules like antibiotics to suppress            
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pathogens) and that molecules associated with this paradigm have been shown to inhibit growth              
of human pathogens is exciting because it represents an ecologically-guided pathway to            
discovering new antibiotics with a higher probability of success in humans, as they are already               
compatible with animal hosts.​7 
One such antibiotic is nocamycin O, an analog of nocamycin I (also known as              
BU-2313B). It was isolated from a bacterium in the genus ​Amycolatopsis​, a symbiont of              
Trachymyrmex smithi ​that is another type of Actinobacteria. Four different isolates of            
Amycolatopsis were tested by Rose Kim (a previous researcher in the Van Arnam Lab) for               
potential antibiotic activity; the most inhibitory isolate, 17SM-2, was selected for further study.             
This strain was subjected to resident-intruder assays to determine whether the compound it             
produced had antifungal or antibacterial activity (Figure 2): 
 
Figure 2: ​Resident-intruder assays to evaluate antifungal (left) and antibacterial (right) activity 
in 17SM-2, from Kim et. al. (2019). 
The antibacterial compound was extracted from the bacteria and then fractionated, first using             
C18 chromatography and then high-performance liquid chromatography (HPLC). The most          
active fraction was then subjected to liquid chromatography-high resolution mass spectrometry           
(LC-HRMS). This analysis showed a (M+H)+ peak of 520.2187, which gives a molecular mass              
of 519.2133 +/- 0.0051. Additionally, no matches were found in the Dictionary of Natural              
Products, indicating that this antibiotic is possibly a novel find.​11 Similarities between nocamycin             
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I data and preliminary MS data for nocamycin O support the idea that it belongs to the                 
nocamycin family (Figure 3). The strongest support for this idea, however, comes from             
biosynthetic gene cluster analysis; >75% of the genes encoding nocamycin I are very similar to               
genes for nocamycin O, and all genes except one have an analog in the other genome. One- and                  
two-dimensional NMR (nuclear magnetic resonance) experiments were used to elucidate a           
tentative structure. 
 
Figure 3: ​Mass spectrometry results with tentative structure for (A) nocamycin O and  
(B) nocamycin I. nocamycin I data from Cogan et. al. (2020). 
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Since the mechanisms of nocamycin I and O inhibition have not been well studied,              
research on similar molecules was conducted to gain a better idea of ways in which these                
molecules could potentially inhibit bacterial growth. Chemically similar (and better          
characterized) relatives include tirandamycin and streptolydigin, also part of the tetramic acid            
family. It has been well-documented that streptolydigin inhibits bacterial growth by interfering            
with bacterial RNA polymerase by binding to its Stl pocket, bridge helix, and trigger-loop              
regions; part of its structure is close enough to contact the backbone of the DNA nontemplate                
strand, allowing streptolydigin to interfere with RNAP function through direct interactions with            
the DNA.​12 This is relevant because while streptolydigin has a similar structure to the nocamycin               
family, it is different enough that the binding affinity and properties may be much different.               
Nocamycins I and II are unique from the rest of the family in that they have a fused tricyclic ring                    
system, while others such as streptolydigin and tirandamycin have a bicyclic system (Figure 4).  
 
Figure 4: ​Structure comparison of nocamycin O (A), nocamycin I (B), streptolydigin (C),  
and tirandamycin (D).  
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Streptolydigin is a known inhibitor of bacterial RNA polymerase in a number of Gram-positive              
bacteria. Nocamycin I (the closest chemical relative to nocamycin O) also demonstrates broad             
antimicrobial activity against many Gram-positive and a few Gram-negative bacteria.​13-15 These           
bacteria include the two anaerobes ​Bacteroides fragilis ​and ​Propionibacterium acnes and the            
aerobe ​Streptococcus pyogenes​, a known cause of infections such as tonsillitis, scarlet fever,             
cellulitis, and necrotizing fasciitis in humans.​13,14 Additionally, it was noted that increasing the             
size or chain length of the 5’ substituent (a synthetic addition to the the CH​2 carbon in the                  
tetramic acid ring) led to a decrease in efficacy of the antibiotic, with the most effective synthetic                 
nocamycin I analog having a methyl substituent in the R​1 position; it was still not as effective as                  
the original compound.​14 This has implications for nocamycin activity in comparison to other             
tetramic acid antibiotics like streptolydigin; most of those implications have to do with structure              
and how the antibiotic associates with its target, bacterial RNA polymerase. Though it is              
currently unknown how or whether nocamycin interacts with RNA polymerase to inhibit            
bacterial growth, based upon its structural similarities to streptolydigin, our knowledge of how             
streptolydigin interacts with RNA polymerase, and the similar activity profiles between the two             
(both inhibit bacteria in the ​Streptococcus ​family and the ​Bacillus family, as well as ​Neisseria               





Figure 5: ​[1] streptolydigin (in purple) associating with bacterial RNAP  and [2] all of its van 
der Waals interactions (blue dashes) and hydrogen bonds (green arrows) with RNAP, from 
Temiakov et. al. (2005). 
It has been suggested that the streptolol portion (the portion containing the bicyclic ring              
system) of streptolydigin is the main determinant of its affinity for RNA polymerase; the              
tetramic acid portion of the molecule has no specific binding sites on the protein surface and thus                 
cannot contribute to its interactions with RNA polymerase, and may even weaken them.​15 The              
sugar moiety (the six-membered ring containing carbons 1”-5” in Figure 4) also has no contact               
with RNA polymerase; it may even hinder streptolydigin binding by competing for positions             
with other parts of RNA polymerase.​15 Nocamycin O lacks both a bulky tetramic acid portion               
and a sugar moiety, as it contains only a five-membered nitrogenous ring in that region (Figure                
3). Assuming that nocamycin O maintains a similar conformation/orientation toward RNA           
polymerase as streptolydigin upon binding with it, nocamycin O could potentially inhibit RNA             
polymerase more efficiently than streptolydigin. The hydrogen bond with ​𝛽​R548 can be            
maintained, as that part of nocamycin O is structurally identical to streptolydigin, and the              
hydrogen bond lost by the replacement of the acetamide could easily be filled by the nitrogen in                 
the tetramic acid ring of nocamycin O. In addition, nocamycin O also contains an -OH group on                 
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one methyl substituent of the tricyclic system, which opens up the possibility of             
additional/previously unobserved noncovalent interactions with the hydrophilic/polar amino        
acids in that region of RNA polymerase (Figure 3). The combination of the less bulky tetramic                
acid group and the additional hydrogen bonding opportunity implies that nocamycin O could be              
an even stronger inhibitor of RNA polymerase than either nocamycin I or streptolydigin, and that               
is has potential as an antibiotic against human pathogens as well. Additionally, there is already a                
precedent for the addition of an -OH group at this position, as tirandamycin B, another tetramic                
acid antibiotic, has this addition.​17 
As shown by the importance of chemical structure in the functioning of streptolydigin,             
proper elucidation of chemical structure is an important first step in determining how a molecule               
functions ​in vivo​. Thus, proper determination of the structure of nocamycin O will be an integral                
and enlightening step toward the discovery of its relationship with RNA polymerase and its              
binding properties, as well as an integral component to its establishment as a novel molecule.               
One method that has been briefly mentioned was selected for this task: NMR spectroscopy. The               
utility of NMR spectroscopy and related theoretical models in terms of structure determination             
will be discussed below. 
 
NMR Spectroscopy and its Theoretical Supplements 
NMR spectroscopy is useful for several reasons; it is a non-destructive technique (the             
molecule does not decay after analysis), it has a wide range of applications in almost every                
branch of science, and it has hundreds of different types of experiments meant to reveal different                
aspects of the molecular structure.​18 In the most basic sense, NMR involves exciting the nuclei of                
the molecule in a specific way by generating a series of radiofrequency and/or magnetic gradient               
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pulses followed by signal acquisition to gather the desired information about the molecule. This              
information can then be compiled into a readable format from which a molecular structure can be                
obtained.  
In an ideal situation, issues caused by suboptimal experimental environments and           
background noise in NMR acquisition would be minimal, but in practice, the spectra obtained              
depend a great deal on external factors, many of which are mechanical- or solvent-related.              
Common causes of inaccuracy in chemical shift assignments include distorted or hidden peaks             
caused by misplacement of the magnets (incorrect shimming) or poor signal-to-noise ratio,            
insufficient acquisition time, and most importantly, broad peaks caused by decreased sensitivity            
of the experiment due to insufficient sample volume.​18 It is clear that spectral complexity              
impedes proper structural determination in experimental NMR acquisition, and with larger           
molecules, this issue is compounded due to the possibility of peaks appearing on top of each                
other, a phenomenon known as spectral crowding. However, it should be noted that many of               
these issues can be addressed by simply changing the modality or phase state of the experiment.                
Many problems associated with 1-dimensional solution-state NMR can be fixed either by            
transitioning to solid-state NMR or by performing multiple 2-dimensional experiments, as these            
will show where couplings occur on the crowded 1H-NMR spectrum. In addition, theoretical             
calculations can be used to help confirm shift assignments by showing what the shift values for                
each nucleus in a structure should be under various solvent conditions. 
 
NMR Theory and the Importance of Chemical Shift Calculations in Structure Determination 
Presently, computational chemistry software packages are becoming more widely known          
as valid alternatives and complements to the experimental methods used to perform certain             
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experiments and calculations. These include energetics calculations, molecular structure         
optimizations, and calculation of the values of various molecular characteristics, including their            
IR (infrared) and NMR spectra. With theoretical calculations, the issues of spectral complexity             
and suboptimal experimental conditions are eliminated. Additionally, NMR chemical shift          
calculations are an excellent way to confirm the structure proposed by the experimental data.              
NMR spectra are created based on the specific behavior of each NMR-active nucleus in the               
molecule in response to an external magnetic field, in this case, a large magnet.​19 The central                
question that NMR helps answer is the determination of chemical structure; assigning shift             
values to each atom in the molecule can help confirm that structure. The basic principle               
underlying NMR and all theoretical models based upon it is that the frequency at which each                
atom’s spin aligns with the external magnetic field is directly related to its chemical              
environment. The frequency at which each atom resonates can be altered by a change to its                
environment, and depending on what changes, can be positive or negative.​19,20 Shielding is             
caused by the electron cloud surrounding each atom; when the external magnetic field is applied,               
the field it induces directly opposes it, which reduces the strength of the external magnetic field                
in that location.​20 Being bonded to more electronegative atoms causes electron density to be              
siphoned away from that specific nucleus, resulting in less of a shielding effect and an increase                
in the shift value.​21 The shift value of each nucleus is a value in ppm (a standardized unit, parts                   
per million, that allows for values taken on different spectrometers to be the same) which is                
usually between 0 and 14 for protons, and directly depends on the frequency (in hertz) that                
causes the atom to align with the external field; more shielded atoms will respond to lower                
frequencies and thus have a lower ppm value.​20 
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An even smaller deviation in the magnetic field can be observed due to the orientation of                
other nearby atoms of the same type. Essentially, while the external magnetic field affects the               
resonant frequency of each nucleus, so do the induced magnetic fields of the nearby atoms.​19,20               
Each of these factors depend on the electron density around each atom as well as the way these                  
electrons affect the local magnetic environment, two things that empirical methods (which assign             
chemical shifts based on prior experimentally-determined values for chemically-similar nuclei)          
fail to account for because they generally ignore electronic contributions. Thus, quantum            
chemical methods such as density functional theory, discussed later in this section, become             
necessary in order to account for these small but important indirect interactions in the overall               
energy of the molecule. 
Empirical methods for calculating shifts involve extrapolation of experimental         
knowledge; data are usually taken from chemical shift tables for each unique molecular             
environment, adjusted based on electronegativity trends, and averaged over the different           
conformers of the molecule to give each atom a unique value in the NMR spectrum.​19 Other                
methods involve a mass search of molecule databases to find molecular environments which are              
chemically similar to the atom currently being analyzed; the advantage of these methods is that               
each can be performed and completed quickly. However, these empirically-based models have            
drawbacks; when the differences in chemical shift are too small, the program cannot reliably              
distinguish between individual magnetic signals, making this type of calculation less useful for             
large molecules like biopolymers and antibiotics. Quantum-mechanical calculations, the primary          
calculation format found in this thesis, use an entirely different approach to predict the chemical               
shifts of the target molecule than empirical methods; this source is primarily the electronic              
structure of the molecule.​19 While empirical methods use previously acquired data and            
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chemically similar matches to construct an NMR spectrum, quantum mechanical calculations use            
the electronic structure to determine the magnetic shielding and spin-spin coupling constants,            
interactions which are determined solely by the electronic structure of the molecule (Figure 6). 
 
Figure 6:​ Taylor series describing the energy of the molecule in terms of the electronic structure 
including magnetic shielding (E​i​(11)​) and spin-spin coupling (E​ij​(02)​), from Gryff-Keller (2011). 
In Figure 6, ​B and ​μ ​are quantities describing the magnetic field and nuclear magnetic               
moments, two quantities which are necessary for calculating the magnetic shielding and coupling             
constants. These are integral for the accurate calculation of the shift value for each nucleus due                
to the utilization of the electronic structure as outlined above. Therefore, these quantities cannot              
be measured using simple analytical techniques; due to the complexity of the connection             
between these parameters and the electronic structure, connections cannot be made between            
spin-spin coupling (small deviations in the field due to signals produced by neighboring atoms),              
magnetic shielding, and other well-defined NMR parameters using empirical methods.​19 Though           
quantum mechanical calculations come with their own set of issues (first and foremost an              
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extremely slow processing rate), a quantum mechanical perspective is helpful for linking NMR             
parameters to molecular structure.  
The major principles used in NMR shift calculations are based upon principles of             
quantum mechanics as applied to molecules, a subset of quantum mechanics known as quantum              
chemistry, whose theories underlie the programs used in computational chemistry. This involves            
the application of mathematical and theoretical principles to the solution of chemical problems             
and can be used to calculate values for chemical properties virtually.​22 Two broader areas of               
quantum chemistry are statistical mechanics and electronic structure theory; of these, the more             
relevant in terms of NMR spectra is electronic structure theory. Electronic structure theory             
utilizes the laws of quantum mechanics rather than classical mechanics to mathematically            
calculate the energy and related properties of molecules while taking into account the atoms’              
electrons, something that molecular mechanics and empirical methods do not do. The only form              
of electronic structure calculations that are entirely quantum theory-based are known as ab initio              
calculations; one of the most commonly used methods in general and the one most often used in                 
terms of this thesis is density functional theory, or DFT.  
Density functional theory (hereafter abbreviated as DFT) appears here to offer a            
compelling alternative to more computationally-taxing methods like Hartree-Fock, which         
involves the approximation of the Schrödinger equation via a complex multivariable wave            
function 𝛹 (x​1​,x​2​,...​, ​x​N ​).​19,23 It simplifies the solution to the Schrödinger equation by employing a               
simpler method to calculate the energies; in DFT, the ​N​-electron wave function and the              
associated Schrodinger equation are replaced with the simpler electron density equation 𝜌(r) and             





Figure 7: ​[1] representing the energy of an atom in terms of its electron density, and [2] the 
ground-state energy with respect to 𝜌, from Parr and Yang (1995). 
Figure 7 shows an equation for the energy of an atom that depends only on the electron                 
density; the Hohenberg-Kohn theorems modified that further to say that it determines all             
properties of the ground state, including the kinetic (T[𝜌]), potential (V[𝜌]), and total (E[𝜌])              
energies.​23 It is important to note that it is impossible to have a true value of F​HK​[𝜌], the universal                   
functional (a function that takes another function as its input) of 𝜌(r), which is notoriously               
difficult to explicitly calculate. However, approximations are fairly easy to do if one assumes              
that the value of F​HK​[𝜌] in a uniform electron gas translates well to real systems.​24 Following the                 
calculation of E[𝜌], the energies with respect to the nuclear magnetic moment ​μ and the external                
magnetic field ​B (as seen in Figure 6) can be compared to the ground-state energy in the absence                  
of these variables, E​0​, and the same theoretical model (in this case, DFT) is then used to generate                  
a simulated NMR spectrum. The calculated chemical shift values for the tentative structure can              
then be plotted against the experimentally determined shift values to make certain that the              
structure and shift value assignments are correct. 
 
NMR in Practice 
In practice, NMR spectra are much easier to understand than the theoretical calculations             
required to simulate them. The principle behind NMR spectroscopy is very similar to that of the                
fluorescence of light; when an external magnetic field is applied, each NMR-active nucleus can              
align their spins either with or against or the magnetic field. When the nuclei are in the xy-plane,                  
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the signal will be visible. As the nucleus relaxes back to align with the z-axis, its signal decays;                  
the different rates at which the nuclei relax and its immediate environment account for              
differences in signal intensity and chemical shift value, respectively. The surroundings for each             
atom play a role as well. For both ​1​H- and ​13​C-NMR (the most often-analyzed nuclei in NMR), as                  
more electron density is shifted away from the nucleus in question, the higher the chemical shift                
gets (Figure 8). Certain functional groups will consistently cause higher shift values, making             
NMR useful for identifying functional groups and determining molecular structure. 
 
Figure 8: ​H-NMR spectrum of ethyl benzoate to illustrate chemical shift, from Balci (2005). 
The splitting of the peaks seen in Figure 8 has to do with the spin orientation of                 
neighboring nuclei, also known as spin-spin coupling. The pattern has to do with the number of                
different nuclei in the immediate vicinity of the nucleus; the CH​2 will be split three times (into a                  
quartet) because its only immediate hydrogen neighbor is the methyl group.​25 Once the spectral              
pattern of one type of nucleus is known, it can be used to assign another type of nucleus and                   
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figure out structure and attachments through two-dimensional NMR, which is the correlation of             
shift values for one type of nucleus with the shift values of another type of nucleus. For example,                  
certain two-dimensional experiments will align proton signals with the carbon signals in their             
surrounding environments, giving information about which proton is attached to which carbon.            
The most common and useful of these heteronuclear two-dimensional experiments are           
Heteronuclear Single Quantum Coherence (HSQC) and Heteronuclear Multiple Bond Coherence          
(HMBC).  
 
Figure 9: ​Overlay of HSQC and HMBC spectrum of ethylbenzene, from Hoffman (2020). 
Signals present on the HMBC that are absent on the HSQC are highlighted in red. 
HSQC is one of many short-range heteronuclear correlation methods. It is especially            
useful because it illustrates exactly which hydrogen is attached to which carbon. All correlation              
signals not highlighted in Figure 9 make up the HQSC spectrum, where each hydrogen signal on                
the horizontal axis has only one correlation to the carbon spectrum on the vertical axis because                
hydrogen can only make one bond. Using this, one can assign hydrogens to their respective               
carbons. HMBC is, as its name suggests, indicative of the carbon associations up to 4 bonds                
away from each hydrogen atom, and can be used to illustrate the chemical environment of each                
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hydrogen.​30,31 As seen in Figure 9, the hydrogens of the methyl group in ethylbenzene are               
coupled to both the carbon in the benzylic position and the first carbon in the aromatic ring, and                  
this is especially useful because that carbon lacks hydrogens and so is invisible on the HSQC.                
Using the HSQC and HMBC spectra in conjunction with the ​1​H spectrum and its splitting is                
often enough to determine the connectivity of the atoms.  
After the connectivity of the atoms is determined, additional spectra can be taken that are               
useful for determining aspects of the molecule’s conformation and orientation in space, such as              
cis/trans alkene structure. The experiment used to detect these changes is known as a ROESY               
(rotating-frame Overhauser Effect spectroscopy) spectrum, which uses Nuclear Overhauser         
Effects to detect small changes in inter- and intramolecular interactions.​28 The Nuclear            
Overhauser Effect can be defined as the enhancement of a spin signal due to the dipole-dipole                
relaxation effect, or more simply, the spin of the excited nucleus relaxes because the              
magnetization is transferred over to the other coupled nucleus in the pair.​28 However, there is an                
amount of artifact that can appear on a ROESY spectrum from protons that are coupled to each                 
other and are fairly similar in chemical shift due to transfer of the signal by proximity or proton                  
exchange.​29 This can be remedied by also performing a TOCSY (Total Correlated Spectroscopy)             
experiment, which is somewhat of a long-range COSY coupling experiment. Any protons that             
show up there are then known to be artifacts on the ROESY.​29 This technique is desirable for                 
discovering the intramolecular reactions as well as the conformation of medium-sized molecules            
such as nocamycin O. 
In cases where spectra are difficult to read due to spectral crowding or a poor signal to                 
noise ratio, more spectra may need to be taken in different solvents to fully understand the                
connections between atoms. In some cases, peaks may even disappear due to proton exchange              
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with the solvent, so it becomes quite challenging to know if the preliminary structure is correct.                
This is where the utility of chemical shift calculations using models like HF and DFT becomes                
apparent. If the structure put into the model is inaccurate, the calculated shifts will reflect that,                
and changes to the proposed structure can be made (and additional NMR experiments run to               
confirm that the changes are correct). As a molecule gets larger, NMR structures become harder               
to solve, and thus chemical shift calculations become more important. Given that most             
biomolecules are somewhat larger and more complex than synthetically generated compounds,           
both NMR and its theoretical counterpart are integral components in chemical and biochemical             
research. 
In order to fully understand the relationship between RNA polymerase and nocamycin O,             
the molecular structure must be comprehensively elucidated. The definitive determination of the            
structure of nocamycin O will be integral in a) determining its novelty, b) allowing us to                
determine how this novelty impacts its interaction with its cellular target, and c) eventually              
conducting trials against a number of pathogens to determine its value in the medical and               
research fields. This study seeks to fully determine the nocamycin O structure using prior NMR               
data collected by students in the Van Arnam lab along with novel 2D NMR data collected                
between January and March of 2020, with complementary ​13​C-NMR chemical shift calculations            
performed using Hartree-Fock and density functional theory. 
 
Methods 
NMR Data Acquisition in MeOD-d​4 
Prior to NMR acquisition, the purified nocamycin O was supplied by Elisabeth Lawton.              
The nocamycin O was evaporated to dryness in a SpeedVac, held under an additional vacuum of                
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approximately 100 millitorr overnight, and redissolved in 200 mL ​of deuterated methanol            
(MeOD-d​4​). All spectra were collected between the dates of February 13 and 28, 2020 on a 500                 
MHz Bruker BioSpin GmbH NMR instrument. Additionally, all spectra were collected between            
294.6 and 298.1 K with a 5 mm TXI 1H/ D-13C/ 15N Z-GRD Z8161/ 0208 probe setting other                  
than the initial 1D carbon spectrum, which was collected by Elisabeth Lawton on October 7,               
2019 with a 5 mm PABBO BB/ 19F-1H/ D Z-GRD Z109128/ 0109 probe setting and zgig30                
pulse sequence. The second spectrum collected was a 1D proton spectrum, gathered using pulse              
sequence zg30 with 32 scans. Following the initial proton spectrum, 5 other experiments were              
performed: 2D COSY (pulse sequence cosygpppqf, 8 scans), 2D HSQC (pulse sequence            
hsqcedetgpsp.3, 32 scans), 2D H2BC (pulse sequence h2bcetgpl3, 22 scans), 2D HMBC (pulse             
sequence hmbcetgpl3nd, 62 scans), and 2D ROESY (pulse sequence roesyphpp.2, 14 scans,            
relaxation delay 2.0 seconds). Following acquisition, all spectra were imported to and analyzed             
using MestReNova v12.0.3-21384 software. All heteronuclear 2D experiments were analyzed          
using the previously collected ​13​C spectrum as a reference (which was referenced to the solvent,               
MeOD-d​4​), and the proton dimensions of all experiments were also referenced to the MeOD              
hydrogen peak (a quintet centered at 3.31 ppm). 
 
NMR Data Acquisition in DMSO-d​6 
The previously used sample (MeOD-d​4​) was evaporated to dryness in a SpeedVac,             
redissolved in 1 mL ​of regular methanol (MeOH), and allowed to sit at room temperature for 16                 
hours so that proton exchange could occur. The sample was then re-evaporated to dryness on the                
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SpeedVac, further held under vacuum at approximately 100 millitorr for 15 hours, and finally              
redissolved in 200 mL ​of DMSO. Additional NMR data was collected on the 500 MHz Bruker                
BioSpin GmbH with probe setting 5 mm TXI 1H/ D-13C/ 15N Z-GRD Z8161/ 0208.              
Temperature was not controlled for these experiments. The first spectrum collected was a 1D              
proton spectrum (pulse sequence zg30, 32 scans), followed by a 2D HSQC (pulse sequence              
hsqcedetgpsp.3, 32 scans), 2D HMBC (pulse sequence hmbcetgpl3nd, 64 scans), 2D COSY            
(pulse sequence cosygpmfppqf, 32 scans), 2D H2BC (pulse sequence h2bcetgpl3, 96 scans), 2D             
ROESY (pulse sequence roesyphpr.2, 32 scans, relaxation delay 2.0 seconds), and a 2D TOCSY              
(pulse sequence mlevphpr.2, 32 scans). An attempt to capture a 1D carbon spectrum was              
unsuccessful due to low probe sensitivity, so all spectra were referenced using the successful 1D               
proton spectrum (which was referenced to the DMSO peak at 2.50 ppm) and the solvent peak                
present in the carbon spectrum (the only definitive peak present at 39.50 ppm). All spectra were                
analyzed in MestReNova v12.0.3-21384 and shift values were assigned.  
  
Chemical Shift Calculations 
Following initial NMR data acquisition, chemical shift calculations for the proposed            
structure of nocamycin O as well as for the chemically similar compound nocamycin I were               
generated. This was done using Spartan ’18 molecular modeling software and precisely followed             
a procedure outlined by Hehre et. al. as summarized below.​30 
The first step was performed using a systematic or sparse-systematic conformational            
search using the MMFF (Merck Molecular Force Field) molecular mechanics model to remove             
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any extremely high-energy conformers present in the initial search; all conformers with energies             
more than 40 kJ/mol above the lowest-energy conformer were discarded. In step 2, the              
Hartree-Fock method was utilized along with the 3-21G basis set to calculate equilibrium             
geometries for each conformer (between 20 and 25 are typically left at this stage). All               
conformers outside of a 40 kJ/mol energy threshold were again eliminated, as well as any               
duplicate conformers. In step 3, the ωB97X-D density functional model was used with the              
6-31G* basis set to recalculate energies with a more accurate molecular model, and all              
conformers with a relative energy greater than 15 kJ/mol were discarded.  
Steps 4 and 5 endeavored to repeat steps 2 and 3 under stricter molecular models and                 
with more accurate basis sets. In step 4, the ωB97X-D density functional model was used with                
the 6-31G* basis set to recalculate equilibrium geometries for the remaining conformers,            
eliminating those with a relative energy greater than 10 kJ/mol. Step 5 recalculated conformer              
energies (usually around 8 or 9 conformers are left at this stage) with the ωB97X-V density                
functional model and the 6-311+G(2df,2p) dual basis set. After step 5, both ​1​H- and ​13​C-NMR               
spectra were generated for all conformers with a relative energy less than 10 kJ/mol and each                
shift value was averaged according to Boltzmann weight.  
 
Results 
 NMR in MeOD and dDMSO - Experimental Results 
The preliminary structure of nocamycin O was largely confirmed and supported by the             




Figure 10: ​Spectral data for nocamycin O in MeOD (values obtained via 1D ​1​H- and ​13​C-NMR). 
The initial data was mostly sufficient to prove most of the structure previously proposed as               
correct; however, two issues were identified through the NMR data collection. The first problem              
was that it was suspected that several 𝛼-hydrogens had been replaced with deuteriums. This is               
most clearly seen in the signal for C-19, where no proton signals were observed (even though it                 
should show up as a CH​2​). This necessitated another round of data collection in an aprotic                
solvent, which will be discussed later in this section. The second problem was the low               
confidence of the chemical shift assignment at C-4, likely because of the scarcity of protons in                
that region of the molecule. There were no HMBC, H2BC, or COSY signals coupled to that                




Figure 11: ​Key NMR correlations (COSY - green, HMBC - pink) in MeOD. 
The HMBC and H2BC coupling signals were extensive and useful for confirming the tricyclic              
structure of the upper part of the molecule. However, there is less evidence supporting the -OH                
group at C-23, as C-19, which is adjacent, was not coupling to anything. This was due to proton                  
exchange at that location; however, the fact that the shift value of C-23 is greater than 60 ppm is                   
indicative of its likely attachment to an oxygen atom. The inability to confirm the existence of                
the -OH group or the assignment at C-4 necessitated more data collection. dDMSO was chosen               
as the aprotic solvent (as it easily dissolves water-insoluble compounds), and the compound was              
redissolved, first in MeOH to reverse the proton exchange, and then in dDMSO. The same               
spectra were obtained for the compound in dDMSO as in MeOD, with the addition of a TOCSY                 
spectrum. Spectral assignments as well as splitting and coupling constants for the proton             




Figure 12: ​Spectral data for nocamycin O in dDMSO (values obtained via 1D ​1​H-NMR  
and 2D HSQC). 
Following the second round of data collection, the issues relating to insufficient data at              
C-19 and C-23 were resolved. Both protons attached to the carbon at C-19 became visible               
(though their splitting is somewhat unclear due to the dDMSO solvent peak present at 2.50 ppm                
and the CH peak from H-21 at 2.88 ppm). The new visibility at C-19 means that all three CH​2                   
carbons originally proposed to be a part of the structure are now fully confirmed, a finding that                 
can be corroborated by the phase-edited HSQC (in which all CH​2 peaks show up as blue instead                 
of red). This increases the likelihood that nocamycin O is a novel member of the nocamycin                
family (the spectrum for nocamycin I, its nearest relative, has only two CH​2 groups).​31 However,               
this experiment was not without its issues. Neither -OH proton appeared coupled to anything;              
28 
 
there were some extremely wide signals around the 2.90-3.0 ppm region, but due to the presence                
of the C-19 proton, it was difficult to tell if that was the signal of only one proton or of two                     
protons crowded together (Figure S12). ​Additionally, insufficient signal-to-noise prevented us          
from obtaining an interpretable ​13​C spectrum, so while any carbons that had HSQC or HMBC               
couplings could be identified, anything that had no homonuclear or heteronuclear proton            
associations became invisible. Thus, the carbon at C-4 had no confirmed chemical shift value              
because it had no HMBC or H2BC correlations (Figure 13). 
 
Figure 13: ​Key NMR correlations (COSY - green, HMBC - pink) in dDMSO. 
Given the HMBC signals between C-1, C-2, and C-3, the COSY correlation between C-2              
and the NH, the prior data in MeOD, and the similarity of the MS/MS and NMR data to that of                    
nocamycin I, the chemical identity of the carbon at C-4 is likely that of an alkene/𝛼-carbon,                
though its actual identity and shift value cannot be confirmed based on the             




Confirmation of Experimental Chemical Shift Assignments - DFT in Spartan ‘18 
To confirm that the proposed structure was correct, chemical shift calculations utilizing            
density functional theory were performed in Spartan ‘18 in order to compare the             
experimentally-determined value with the calculated value of each nucleus. The results of those             
calculations as compared to the experimental shifts in MeOD are shown below (Figure 14): 
 
Figure 14: ​Comparison of experimental chemical shift values (MeOD) to calculated values. The 
proton values for C-19 (2.2, 2.8) are a paler color because they had no experimental equivalent. 
The calculated and experimental carbon shift values were overall in agreement for the tricyclic              
portion of the molecule and slightly less in agreement for the olefinic middle portion of the                
molecule. The calculated proton shifts did not appear to follow a pattern in terms of which parts                 
of the molecule had more accurate values. Overall, the calculated values did agree with the               
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experimentally determined values, especially for the carbon spectrum. The dDMSO comparisons           
followed a largely similar trend (Figure 15): 
 
Figure 15: ​Comparison of experimental chemical shift values (dDMSO) to calculated values. 
The carbon value for C-4 (102.1) is a paler color because it had no experimental equivalent. 
Several of the experimental ​13​C chemical shift values in the olefinic section of the molecule were                
more similar to the calculated values than their counterparts measured in MeOD, namely C-5 and               
C-8. The proton shifts were marginally further from the calculated values in dDMSO, but the               




Residual Analysis of Density Functional Calculations  
To ensure that the results of the density functional calculations could be considered             
accurate and that there was not an unknown source of systematic error present in the protocol,                
residual analysis was performed comparing the calculated chemical shift values to the            
experimental values in both MeOD and dDMSO (Figure 16): 
 
Figure 16: ​Residual analysis comparing the calculated chemical shifts to the experimental 
values. All trendlines follow the linear least squares fit model and R​2​ values closer to zero are 
indicative of less correlation between chemical shift value and magnitude of error. 
The residual analysis of the calculated and experimental values reveals no significant or             
worrying trends in the data; while the residual values for the carbon shifts do get larger as the                  
chemical shift values increase, the graph, the trendline and the R​2 value show that this error is not                  
systematic (i.e. all positive errors or all negative errors). Thus, the protocol can be considered               
reliable and the calculated chemical shift values that it generates can be considered accurate. 
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Confirmation of Novelty - Comparison of Nocamycin I and Nocamycin O 
Perhaps the most important part of the study of this compound is its confirmation as a                
novel compound. Thus, a comparison study between nocamycin O and nocamycin I (its most              
chemically similar relative) was conducted to determine if there were any significant and/or             
obvious differences in data collected for the two compounds. This study was done using data               
analysis of previously collected NMR data for nocamycin I and density functional calculations to              
generate calculated chemical shift values for nocamycin I.​31 A table comparing the            
experimentally derived chemical shift values of nocamycin I and nocamycin O in MeOD is              
shown below (Figure 17): 
 
Figure 17: ​Comparison of experimental chemical shift values for nocamycin I (from Mo et. al. 
2017) and nocamycin O (both in dDMSO). Proton shift differences of greater than 0.4 ppm and 
carbon shift differences of greater than 3 ppm have been highlighted. 
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As shown in Figure 17, C-2, C-5, C-6, C-7, C-9, C-19, and C-23 have marked differences in                 
either their carbon or proton chemical shifts. The differences in chemical shift values seen in the                
olefinic section (C-5 to C-9) of the molecule likely have nothing to do with structural changes to                 
the compound but rather conformational changes and a subsequent difference in the environment             
of these carbons in space. This theory was supported by the differences seen in the               
conformations best supported by the density functional calculations performed on nocamycin I            
and nocamycin O, as those conformations appeared to be quite different (Figure 18). 
 
Figure 18: ​Conformational differences between best conformer of nocamycin O (top) and 
nocamycin I (bottom). Skeletal structures included for clarity. 
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The theory that nocamycin O adopts a novel conformation as compared to nocamycin I,              
and is therefore a novel molecule, is further supported by the additional ROESY spectrum              
gathered for the compound (Figure 19): 
 
Figure 19: ​ROESY (2D proton correlation) spectrum for nocamycin O. 
Though there is a considerable amount of t2 and t1 noise confounding the readings closer to the                 
diagonal, quite a few interesting observations can be made based on the data further away from                
it. Notably, both 5.65 ppm (C-9) and 0.92 ppm (C-12) appear to be correlated with protons that                 




Figure 20: ​All ROESY correlations present on the spectrum in dDMSO. Purple arrows represent 
true NOE, while black arrows represent artifact that is also seen on the TOCSY (Figure S14). 
C-9 (5.65 ppm) appears to be correlated with C-26 (3.70 ppm), C-10 (2.75 ppm) appears to be                 
correlated with C-2 (3.32 ppm), and C-12 (0.92 ppm) appears to be correlated with C-23 (3.38                
ppm), none of which are structurally near each other at all. None of these three key correlations                 
appear on the TOCSY either, so it is unlikely that the correlations are artifacts or errors.                
Therefore, they must be spatially close to each other, as that is the only explanation for the                 
signals correlations. These observations point to a unique conformation of nocamycin O similar             
to that shown in Figure 18 (though not exactly like that, as that conformation would make the                 
correlation of C-26 and C-9 very unlikely). This is overwhelmingly due to the addition of the                
-OH group, which allows different and/or previously unobserved hydrogen bonding          





Structure Confirmation of Nocamycin O 
The two rounds of experimental NMR data acquisition (in MeOD and then dDMSO)             
each individually confirmed certain aspects of the compound’s structure. The MeOD run            
contained 26 different carbon signals (plus an additional one that was eventually discovered to be               
residual formic acid from the HPLC extraction), which supported the structure based on the              
significant genetic similarity between nocamycin O and nocamycin I (discovered through the            
analysis of the biosynthetic gene cluster) as well as the MS results (Figure 3). However, the lack                 
of proton signals at C-19 made it difficult to confirm the presence of the -OH group at C-23,                  
which was also suggested by the 16-amu mass difference between the MS results for nocamycin               
I and nocamycin O. Due to this lack of coupling and resulting ambiguity of which shift value                 
belonged to C-19 and which belonged to C-23 (the MeOD shift values at those positions were                
46.0 and 61.1 ppm, and 61.1 was first incorrectly assigned to C-19), more data collection was                
deemed necessary. The second data collection was done in dDMSO after a brief solvation in               
MeOH to exchange the protons back, and this time there was enough information to confirm the                
identities of C-19 and C-23, but no shift at all was seen for C-4 due to insufficient reach of the                    
HMBC couplings and lack of a decent ​13​C spectrum due to poor signal-to-noise ratio (Figure 13).                
Though the inability to confirm C-4 in dDMSO was undesirable, the restoration of the CH​2 at                
C-19 means that the tricyclic structure of the upper portion of the molecule as well as everything                 
from C-5 onward can be fairly confirmed via the HMBC and COSY correlations in dDMSO,               
which are more extensive than those seen in MeOD (Figures 11 and 13). However, other than the                 
singular NH coupling seen in the ROESY spectrum (Figure 19), no other heteroatomic couplings              
appear to be observed on either of the HMBC or H2BC spectra. It is somewhat likely that some                  
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additional proton exchange may still be present in the sample via hydrogen bonding (especially              
at the -OH attached to C-5), thus rendering some or all of the -OH groups invisible on said                  
spectra. Even though the spectrum mostly confirms the predicted structure (and agrees with the              
MS data) further NMR spectrometry analysis should be conducted on the compound (specifically             
a new HMBC of the compound that contains the missing -OH groups, as this is the only                 
spectrum they are likely to appear on) to ensure that this conclusion is correct and to visualize all                  




The density functional theory calculations were additionally helpful for solving the issue            
of whether the shift at C-23 was 46 or 61 ppm. However, the amount of error present for other                   
parts of the molecule did begin to raise questions about the validity of the protocol. While most                 
of the carbon shift calculations were within the acceptable error range, the approximations were              
noticeably bad for C-5 through C-8 (the olefinic section of the molecule), as well as for many of                  
the proton shifts. An acceptable margin of error for this protocol (as defined by the authors) is                 
approximately 4-5 ppm for carbon shifts and less than 0.2 ppm for proton shifts, and there were a                  
few carbon shift values that were off by 10 ppm or more.​32 While there does not appear to be any                    
systematic error associated with the protocol, the approximations for the carbon shifts also             
appear to get less accurate as the experimental shift value increases, a trend that is more                
noticeable in the dDMSO residual plot but is present in both (Figure 16). There are several                
possible reasons for these inaccuracies; those which are most relevant here are conformational             
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effects on the experimental results, accuracy of the calculations and its impact on the Boltzmann               
weight assigned by the program, and the complex nature of the calculation of proton spectra. 
Possibly the factor having the largest impact on the accuracy of the DFT calculations is               
conformational change in the experimental sample, which may be solvent-related or not. As a              
molecule with a fair amount of free rotation and cis/trans alkene options, nocamycin O has               
thousands of possible conformations. Its possibilities are somewhat restricted due to the            
ring-locked conformation of the upper region of the molecule, but the olefinic section of the               
molecule has numerous possible conformations and shapes. Density functional theory is also            
known to be inaccurate in measuring the shifts of alkenes and alkynes specifically, likely              
because it doesn’t account for these possible conformational differences.​33 Additionally,          
differences in shift values for cis and trans forms of the same alkene can be between 0.2 and 0.4                   
ppm, while carbon shifts have an even larger margin of error.​34 The DFT calculations were also                
performed in the gas phase, which ignores any effects the solvent could possibly have on the                
conformation of the molecule. Thus, it is likely that the conformational distribution for             
nocamycin O is different in the gas phase and the solvated phase, resulting in particularly large                
errors in the most conformationally flexible region.  
Inaccuracies created by the program also include errors stemming from the accuracy of             
the model that the calculations favor as well as the Boltzmann weight determined by the program                
in the final step. If the Boltzmann weight in the gas phase is different from the actual                 
conformational distribution, this could result in an inaccurate approximation of the chemical shift             
values for those conformationally diverse areas, on the order of 5-8 ppm.​32 The Boltzmann              
weight seen ​in silico ​can also have a great effect on the calculated J values (coupling constants)                 
which are helpful for determining the splitting and chemical identity of peaks in proton              
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spectra.​32,35 This is important for the accuracy of the proton spectrum because the coupling              
constants are the second derivatives of the energy with respect to the nuclear magnetic moment               
μ​. This quantity is determined by the program solely using the electronic structure of the               
molecule, which is extremely conformation-dependent.​19,36 Thus, the proton spectra are more           
likely to be incorrect if solvent effects on molecular conformation are not taken into account. The                
carbon spectrum does not appear to be as sensitive to this, though the increase in residual error as                  
the ​13​C shift values increase does represent a possibly problematic issue with the protocol.              
Overall, the DFT calculations represent a decent confirmation of the structure of nocamycin O,              
but the values only appear trustworthy for the non-olefinic portions of the ​13​C spectrum. To               
ensure accuracy of the calculations and determine whether solvent interaction really has a large              
effect on conformation and on the calculated shift values, the calculations should be performed              
again in Spartan ‘18 under polar solvent conditions instead of in the gas phase. 
 
Nocamycin O as a Novel Member of the Nocamycin Family 
Perhaps the most successful portion of this thesis was the confirmation of nocamycin O              
as a new compound and a member of the nocamycin family. The analysis of the experimental                
NMR shift values for nocamycin O and nocamycin I revealed no large differences in a               
considerable portion of the molecule, indicating that the molecules are definitely chemically            
similar (Figure 17). However, certain areas of the molecule exhibited extremely large differences             
in shift values, namely C-2, C-5, C-6, C-7, C-9, C-19, and C-23. Most notably, the carbon shift                 
value at C-23 increased nearly 38 ppm from nocamycin I to nocamycin O, while the proton shift                 
value increased by nearly 2 ppm. The standard shift for a methyl group (C-23 identity in                
nocamycin I) is around 10-15 ppm, though C-23 is understandably a bit higher due to its                
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surrounding oxygen atoms. The carbon shift value for an RCH​2​OH methylene carbon is between              
50 and 90 ppm; the C-23 value for nocamycin O falls right into this range at 59.58 ppm.​37 This                   
supports a change in the chemical identity of C-23, and it also supports the idea that the addition                  
at C-23 is an -OH group. The 16-amu difference in the MS data for the two compounds basically                  
confirms this idea, because that would correspond to an identical molecule with one additional              
oxygen atom (Figure 3). 
Other marked changes include the drastic differences seen in the olefinic section of the              
molecule (C-5, C-6, C-7, and C-9). Each of these carbons has a shift differential between 5 and                 
10 ppm, a significant amount of difference to be sure, but not enough to indicate an additional                 
atom in the region.​37 Instead, the difference in chemical shifts at these positions is more likely to                 
be a result of a change in the chemical environment directly adjacent to the nuclei. The                
experiment used to detect these changes was a ROESY spectrum (Figure 19). Our ROESY              
experiment detected several interesting interactions between structurally distant parts of the           
nocamycin O molecule. C-12 (0.92 ppm) appears to be correlated with at least one of the protons                 
in the CH​2 group at C-23 (3.38 ppm), and C-9 (5.65 ppm) and C-26 (3.70 ppm) are also                  
correlated, as well as C-10 (2.75 ppm) and C-2 (3.32 ppm). As these nuclei are too far apart to                   
couple on anything dependent on bond interaction (i.e. an HMBC or H2BC), the only              
explanation for this coupling is that magnetic transfer is occurring through spatial association             
between the nuclei. The DFT calculations support this association as correct; the collapsed             
conformation of nocamycin O appears to be more stable than the linear, stretched-out             
conformation that nocamycin I favors. The linear conformation also would not allow the             
association of any of these three pairs, because they are extremely far apart in the linear                
conformation (Figure 18). This in conjunction with the drastic differences seen between the             
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experimental spectra for nocamycin O and nocamycin I point to nocamycin O being a closely               
related but novel member of the nocamcyin antibiotic family. 
 
Conclusion 
This thesis sought to fully elucidate the structure of nocamycin O, a novel antibiotic,              
using experimental and theoretical methods to confirm its place in the nocamycin family and also               
its distinct differences from all known members of said family. The experimental NMR data              
confirmed its novelty (especially when compared to its structurally similar analog nocamycin I),             
but there were several holes in the structure data that will have to be addressed in order to                  
definitively confirm the correct structure. Chemical shift calculations served to confirm that most             
of the ​13​C shift assignments made experimentally were correct; the calculated proton shift values              
were less accurate, and calculations should be re-run in a polar solvent environment to determine               
if that has any effect on the accuracy of the proton shift approximations. Finally, a combination                
of both of these elements helped to further prove the novelty through spatially-dependent proton              
couplings (ROESY) present on the spectrum for nocamycin O that were not present for              
nocamycin I, as well as conformer analysis using DFT that showed extremely different preferred              
geometries for the two molecules.  
Through this structural analysis, nocamycin O is shown to be a novel member of the 
nocamycin family. Given that other members of this family, as well as other tetramic 
acid-derived compounds like streptolydigin, have potent antibacterial effects due to their 
inhibition of RNA polymerase, this points to nocamycin O as an exciting area for future study as 
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Section 1: MeOD NMR Data 
 




















Figure S6: ​2D HMBC spectrum of nocamycin O in MeOD.  
 
Figure S7: ​Comprehensive correlation table of all correlations/couplings seen in MeOD. 
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Section 2: dDMSO NMR Data 
 






























Figure S15:​ Comprehensive correlation table of all correlations/couplings seen in MeOD. 
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